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INTRODUCTION
Peripheral nerve injury caused by trauma is associated with
spontaneous pain, allodynia, and hyperalgesia. These neuro-
pathic pain symptoms are often poorly relieved by conven-
tional analgesics, such as opioids and non-steroidal anti-in-
flammatory drugs (1, 2). Although the mechanisms under-
lying neuropathic pain have not been fully understood, it is
known that excitatory amino acids, including glutamate, play
a key role in the alteration of the spinal sensory processing
and the plasticity of dorsal horn neurons after nerve injury
(3, 4). In the search for alternative treatment, anticonvulsants
have been found as a pharmacological intervention for patients
with neuropathic pain, because the mechanisms of convulsion
may be similar to those of neuropathic pain. Gabapentin as
an anticonvulsant drug has attracted recent attention because
of its effectiveness against neuropathic pain in clinical trials
and animal experiments. Although the mechanism of the anti-
nociceptive action of gabapentin remains unclear, it has been
demonstrated that gabapentin decreased glutamate concen-
tration and elevated  -amino-butyric acid (GABA) concen-
tration in the central nervous system of rat (5-7). 
Previous studies have shown that gabapentin produced an
antinociceptive effect in the various facilitated pain models
(8-14) and intrathecal gabapentin was effective against allo-
dynia in neuropathic pain (15, 16). The antinociceptive effect
of systemic administration of gabapentin was observed at
doses below those producing its side effects, including behavior
or motor dysfunction (17-19). However, it has been uncer-
tain whether intrathecal gabapentin is effective in mechani-
cal and thermal hyperalgeia in neuropathic pain induced by
nerve injury and whether its effect is accompanied with any
side effect on motor function. 
Therefore, we examined whether intrathecal gabapentin
produces the antinociceptive effect on thermal and mechan-
ical hyperalgesia in neuropathic rats induced by spinal nerve
ligation, and whether the antihyperalgesic effect of gabapentin
is affected by motor dysfunction. 
MATERIALS AND METHODS
Animal preparation
Male Sprague-Dawley rats weighing 150-200 g were housed
in separate cages and allowed to acclimate for 5-7 days by
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The Effect of Intrathecal Gabapentin on Mechanical and Thermal
Hyperalgesia in Neuropathic Rats Induced by Spinal Nerve Ligation
Gabapentin decreases the level of glutamate and elevates that of  -amino-butyric
acid in the central nervous system. Gabapentin was shown to have antinocicep-
tive effects in several facilitated pain models. Intrathecal gabapentin was also
known to be effective in reducing mechanical allodynia in animals with neuro-
pathic pain. In this study, we investigated to see whether intrathecal gabapentin
produces antihyperalgesic effects on thermal and mechanical hyperalgesia in
neuropathic rats and whether its effects are associated with motor impairment.
To induce neuropathic pain in Sprague-Dawley rats, left L5 and L6 spinal nerves
were ligated. After a week, lumbar catheterization into subarachnoid space was
performed. Then, paw withdrawal times to thermal stimuli and vocalization thre-
sholds to paw pressure were determined before and up to 2 hr after intrathecal
injection of gabapentin. Also, motor functions including performance times on
rota-rod were determined. Intrathecal gabapentin attenuated significantly thermal
and mechanical hyperalgesia in neuropathic rats, but did not block thermal and
mechanical nociception in sham-operated rats. Intrathecal gabapentin of anti-
hyperalgesic doses inhibited motor coordination performance without evident
ambulatory dysfunction. This study demonstrates that intrathecal gabapentin is
effective against thermal and mechanical hyperalgesia, in spite of moderate
impairment of motor coordination.
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using a 12/12 hr day/night cycle. The surgical preparation
and the experimental protocol were approved by the Institu-
tional Animal Care and Committee of the Samsung Biomedi-
cal Research Institute. 
Surgical preparation
Ligation of the left L5 and L6 spinal nerves in rats was used
in this study as an experimental model of neuropathic pain.
Rats were anesthetized with 1% halothane in O2 by a mask.
The surgical procedure was performed, according to the
method described by Kim and Chung (20). A dorsal mid-
line incision was made from L3 to S2. The left L6 transverse
process was resected in part to visualize L4, 5 spinal nerves.
The left L5 spinal nerve was isolated and ligated tightly with
6-0 black silk just distal to the dorsal root ganglion. The left
L6 spinal nerve was isolated below the iliac crest and ligated
tightly with 6-0 black silk. After recovery from anesthesia,
rats that were unable to withdraw the left hindpaw were ex-
cluded from the study. The rats in which the thresholds to
thermal and mechanical stimuli after nerve ligation were de-
creased more than 20% than those before nerve ligation were
included in the study. Sham control rats were prepared in
the same way, except for nerve ligation. The animals were
allowed to recover for 5-7 days before intrathecal cannula-
tion. Intrathecal catheters (PE-10 tube) were inserted into
lumbar subarachnoid space during halothane anesthesia, as
previously described by St rkson et al. (21). Proper placement
of the catheter was determined by the occurrence of hind-
paws paralysis after an intrathecal injection of 10  L of 2%
lidocaine. All pharmacological experiments were conducted
between 2 and 3 weeks after spinal nerve ligation. Each rat
received only a single intrathecal injection of drugs.
Behavioral testing
Thermal response was determined by the left hindpaw
withdrawal times using plantar tester (Stoelting Co, Wood
Dale, U.S.A.) described by modified method of Hargreaves
et al. (22). Rats were allowed to acclimate within plastic enclo-
sures on a clear glass plate maintained at room temperature.
A radiant heat source was controlled with a timer and focused
onto the plantar surface of hindpaw encompassing the glab-
rous skin. Paw withdrawal stops both heat source and timer.
A maximal cut-off of 30 sec was used to prevent tissue dam-
age. Three trials, at least 10 min apart, were conducted and
three withdrawal times were averaged to give a mean with-
drawal time. 
Mechanical response was measured by using Randall-Selitto
algesiometer (Ugo Basile, Comerio, Italy), which generates
a linearly increasing mechanical force. A mechanical stimu-
lus was applied to the dorsal surface of the left hindpaw by a
dome-shaped plastic tip. Mechanical thresholds were defined
as the force in grams at which the rat vocalized. A maximal
cut-off of 400 g was used to prevent tissue damage. Two tri-
als, at least 10 min apart, were conducted and two vocaliza-
tion thresholds were averaged. 
Motor function of hindpaws was evaluated by testing the
animals' ability to stand and ambulate in a normal posture.
We assessed the motor function by grading the ambulating
behavior of rats (16) as the following: 2=normal; 1=limping;
0=paralyzed. 
Motor coordination was tested using an accelerating rota-
rod treadmill (Stoelting Co, Wood Dale, U.S.A.). The rota-
rod was set in motion at a constant speed and the rats were
placed into individual sections of the rota-rod. Once the rats
were in position, the timers were set to zero and rota-rod was
switched to accelerating mode. The rota-rod was operated
at a rate of 4 rpm for 20 sec, and then at 8 rpm for 120 sec
and at 16 rpm for 60 sec (19). The rats were trained in the
test procedure for 5 days before collecting data. The perfor-
mance times were recorded when the rats were unable to stay
on the rota-rod and tripped on the plate. Two trials were per-
formed at intervals of 10 min and performance times were
averaged. 
Experimental protocol
On experiment day, rats were acclimated for 30 min before
testing. Then, baseline thresholds were determined. Rats were
assigned randomly to four groups receiving intrathecal injec-
tion of normal saline (n=6) and three different doses of gaba-
pentin (Parke-Davis, Ann Arbor, U.S.A.): 30  g (n=6); 100
g (n=6); 300  g (n=6). These doses were based on the pre-
vious and our pilot studies. Drugs were dissolved in normal
saline and delivered in a volume of 10  L, followed by a 10
L flush of normal saline, using a gear-driven microinjection
syringe. The thermal and mechanical thresholds and the motor
function in neuropathic rats and sham-operated rats were de-
termined at 30, 60, and 120 min after treatment. The motor
performance on the rota-rod was measured in sham operated
rats. The response threshold data were calculated to a percent-
age of the maximum possible effect (%MPE) according to the
following formula: %MPE=[(postdrug threshold-predrug
threshold)/(cut-off threshold - predrug threshold)] ×100. 
Statistical analysis
Data are presented as mean±SD. Within each of the treat-
ment groups, effects of drugs on thermal and mechanical
hyperalgesia and motor coordination were compared with
pre-treatment values by repeated-measures analysis of vari-
ance, followed by Dunnett analysis of least significance dif-
ference for multiple comparisons. The paw thresholds in
response to thermal and mechanical stimuli before and after
nerve ligation were compared using paired Student's t-test.
A probability level <0.05 was considered to be statistically
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RESULTS
The tight ligation of spinal nerves produced a marked re-
duction in the thermal and the mechanical stimuli which
were necessary to evoke paw withdrawal and vocalization.
The paw withdrawal times were reduced significantly from
11.3±1.5 to 7.7±0.6 sec and the vocalization thresholds
also from 213.2±32.8 to 126.5±21 g.
In spinal nerves-ligated rats, intrathecal gabapentin of 100
and 300  g increased significantly the withdrawal times of
the injured paw in response to thermal stimuli (p<0.05) in a
dose-dependent manner. These effects of intrathecal gaba-
pentin 300  g were observed at 30 min and reached a max-
imum at 60 min (Fig. 1). The percentages of the maximum
possible effect were 48% and 74% at doses of 100 and 300
g, respectively. In sham-operated rats, however, intrathecal
injection of three different doses of gabapentin did not increase
the withdrawal times in response to thermal stimuli (Table 1). 
In spinal nerves-ligated rats, intrathecal gabapentin also
increased significantly the vocalization thresholds in response
to mechanical stimuli (p<0.05), except for gabapentin 30  g.
This effect of intrathecal gabapentin at 300  g was observed
up to 120 min, whereas that of gabapentin 100  g was not
at 120 min (Fig. 2). The percentages of the maximum pos-
sible effect were 31% and 79% at doses of 100 and 300  g,
respectively. In sham-operated rats, however, intrathecal ga-
bapentin did not increase the vocalization thresholds in re-
sponse to mechanical stimuli, except for gabapentin 300  g
(Table 2).
In spinal nerves-ligated and sham-operated rats, intrathecal
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Fig. 1. Changes of withdrawal time of left hindpaw to thermal stim-
uli in spinal nerve-ligated rats. The withdrawal time is increased
significantly (p<0.05) after intrathecal administration of gabapentin
100 and 300  g. The symbols represent mean±SD. *: p<0.05
versus pre-injection.
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Fig. 2. Changes of vocalization threshold of left hindpaw to me-
chanical stimuli in spinal nerve-ligated rats. The vocalization thre-
shold is increased significantly (p<0.05) after intrathecal admin-
istration of gabapentin 100 and 300  g. The symbols represent
mean±SD. *: p<0.05 versus pre-injection.
Time (min)
Vehicle 11.1±0.9 11.5±1.2 11.5±1.4 11.3±1.6
Gabapentin 30 g 11.3±2.0 10.5±1.0 11.0±1.5 11.1±1.1
Gabapentin 100 g 11.8±1.6 11.2±1.7 10.8±1.5 11.0±2.0
Gabapentin 300 g 11.0±1.7 12.0±2.4 10.3±1.4 10.3±1.4
Table 1. Changes of withdrawal time (sec) of left hindpaw to
thermal stimuli after intrathecal injection in sham-operated rats
Pre-injection 30 min 60 min 120 min
Data (sec) are mean±SD (n=6/group).
Vehicle 229±35 216±51 220±52 205±32
Gabapentin 30 g 208±38 209±19 214±44 219±26
Gabapentin 100 g 203±28 205±33 217±17 211±26
Gabapentin 300 g 211±30 337±51* 363±37* 363±43*
Table 2. Changes of vocalization threshold (g) of left hindpaw
to mechanical stimuli after intrathecal injection in sham-oper-
ated rats
Pre-injection 30 min 60 min 120 min
Data (g) are mean±SD (n=6/group). *: p<0.05 versus pre-injection.
Vehicle 164±15 170±9 168±8 172±7
Gabapentin 30 g 165±14 169±14 157±21 155±20
Gabapentin 100 g 167±10 106±42* 89±44* 86±33*
Gabapentin 300 g 161±14 62±25* 83±27* 120±22*
Table 3. Changes of performance time (sec) on rota-rod after
intrathecal injection in sham-operated rats
Pre-injection 30 min 60 min 120 min
Data (sec) are mean±SD (n=6/group). *: p<0.05 versus pre-injection.
*
*
*
* *
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* *
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gabapentin did not decrease the ambulating behavior scores.
However, rats given intrathecal injection of gabapentin 300
g showed the splayed hindpaws. 
Intrathecal gabapentin decreased significantly the perfor-
mance times on rota-rod (p<0.05) in sham-operated rats, ex-
cept for gabapentin 30  g (Table 3).
DISCUSSION
In the present study, intrathecal administration of gaba-
pentin was effective against thermal and mechanical hyper-
algesia in neuropathic pain induced by spinal nerve ligation
and its effect was not limited by motor dysfunction. How-
ever, antihyperalgesic doses of intrathecal gabapentin inhib-
ited the motor coordination performance without evident
ambulatory dysfunction.
The antinociceptive effect of intrathecal gabapentin observ-
ed in the current study agrees with previous observations in
which gabapentin was effective in the various facilitated pain
models. It has been shown that gabapentin attenuated the
various hypersensitive states induced by injection of forma-
lin (8, 9), streptozocin (10), or substance P (14) and reduced
paw incision-induced pain (11, 12) and burn-induced pain
(13). In addition, intrathecal gabapentin decreased mechan-
ical allodynia in neuropathic pain induced by nerve injury
(15, 16). The efficacy of gabapentin in several pain models
suggests the common mechanisms associated with the gen-
eration of a facilitated state of processing. Although the mech-
anism of antinociception of gabapentin has not been known,
several studies suggested that the spinal cord is the primary
site of drug action (8, 9, 11, 13, 15, 16). In our study, we
found antihyperalgesic effect of intrathecal gabapentin at a
higher dose than that producing antiallodynic effect in neu-
ropathic rats. This dose was also higher than that producing
antihyperalgesic effect in formalin-induced pain (8, 9), post-
operative pain (11), and burn-induced pain (13). It may sim-
ply reflect a difference in the stimuli strength that intrathecal
gabapentin has to overcome to produce an antinociceptive
effect in various pain models. It also reflects that intrathecal
gabapentin may produce different sensitivity to different kinds
of abnormal pain.
Previous studies have shown that administration of gaba-
pentin in normal rats did not alter the formalin-induced
behaviors during phase 1 period (8, 9) and the response to
physiologic pain (18). It suggested that antinociception of
gabapentin is not analgesic but antihyperalgesic. We observed
that intrathecal gabapentin of 300  g in sham-operated rats
did not increase the paw withdrawal times to thermal stim-
uli but increased the vocalization thresholds to mechanical
stimuli. This finding is consistent partly with the recent
observation that systemic gabapentin increased vocalization
thresholds of the noninjured paw to mechanical stimuli in
neuropathic rats (17). However, it does not support that rel-
atively high doses of intrathecal gabapentin may produce
analgesic effect in normal physiologic pain. It is known that
the vocalization response to paw pressure is a supraspinally
integrated test and the paw withdrawal response to thermal
stimuli is a spinally coordinated reflex. As gabapentin is poor-
ly soluble in lipid (23), intrathecal gabapentin may spread
cephalad easily and produce the supraspinal effect. There-
fore, the vocalization response may be more susceptible than
the paw withdrawal response to intrathecal gabapentin. 
Although the mechanism of action of gabapentin is not
clear, there are several evidences that N-methyl-D-aspartate
(NMDA) and GABA-mediated events are involved in the
pharmacological action of gabapentin. The glycine/NMDA
agonist reversed the antihyperalgesic action of gabapentin
(19). Furthermore, it blocked the thermal hyperalgesia induc-
ed by intrathecal NMDA (14). Gabapentin has been shown
to increase GABA synthesis (5) and enhance the GABA
release in brain regions (7). Although previous studies have
failed to show any affinity for GABAA or GABAB sites or
any known site associated with its receptor (15, 23, 24), ga-
bapentin may play a physiologic role in the modulation of
the glutaminergic and GABAergic functions that are involved
in the central sensitization of the dorsal horn neurons induced
by injury.
In our study, although intrathecal gabapentin at 300  g
caused the hindpaws to be splayed, it did not obtund the
brisk withdrawal response of hindpaw to thermal stimuli in
sham-operated rats, nor did it inhibit the ambulating ability.
This finding suggests that antihyperalgesic effect of intrathe-
cal gabapentin in neuropathic rats is not limited by motor
dysfunction. Previous studies showed that intrathecal admin-
istration of gabapentin up to 100  g caused no detectable
motor weakness, as judged by placing-stepping reflexes and
ambulating behavior or other visible behavioral changes, such
as sedation and agitation (11, 14, 16). The doses of intrathe-
cal gabapentin less than 300  g did not alter motor responses,
including paw withdrawal response to pinch (15). Further-
more, several observations pointed out a good separation
between the antinociceptive and the side effects of gabapentin
(16-18). Systemic gabapentin was effective in models of
neuropathic pain after sciatic nerve constriction (16, 17) or
formalin-induced pain (18) at doses below those producing
behavior or locomotion dysfunction. However, we found
that intrathecal gabapentin at the doses inducing antihyper-
algesic effect produced motor impairment on rota-rod. It
indicates that intrathecal administration of gabapentin has
narrower ranges of margin of safety than systemic adminis-
tration. As water-soluble gabapentin may move from the
injected site to the brain through cerebrospinal fluid, the
central nervous system that controls locomotion may be
more vulnerable to intrathecal gabapentin than to systemic
gabapentin.
In conclusion, the present study reveals that intrathecal
injection of gabapentin is effective against the thermal andEffect of Intrathecal Gabapentin on Hyperalgesia in Neuropathic Rats 229
mechanical hyperalgesia in neuropathic rats induced by
spinal nerve ligation. This result suggests that gabapentin
may exert potent effects on anomalous pain states with facili-
tated spinal processing by tissue or nerve injury. However,
intrathecal gabapentin at antihyperalgesic doses also causes
the impairment of the motor coordination, which may be
considered as one of its side effects. Therefore, it remains to
be determined whether intrathecal injection of gabapentin
may be a safe intervention for neuropathic pain.
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